We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




15-Minute Blood Test Diagnoses Life-Threatening Infections in Children

By LabMedica International staff writers
Posted on 14 Nov 2025

Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. More...

Traditional tests can take hours, leaving clinicians to rely on their judgement or prescribe precautionary antibiotics while awaiting results. Now, a new trial is evaluating a rapid 15-minute blood test designed to identify whether an infection is viral or bacterial, enabling faster and more accurate treatment decisions for children.

The trial, which is underway at three hospitals in the UK, including St Mary’s Hospital, Imperial College Healthcare NHS Trust (London, UK), runs until March 2026 and involves testing children who arrive at emergency departments with fever or suspected infection. The new test provides clinicians with crucial diagnostic clarity in just 15 minutes.

By showing whether an infection is bacterial or viral, it offers an important advantage over conventional laboratory testing, which can take several hours to produce results. Faster diagnosis means patients can be treated sooner and antibiotics can be reserved for cases where they are truly needed, reducing the risk of missed serious infections while also preventing unnecessary prescribing.

The trial aims to understand how real-world emergency teams will use this rapid test and whether it improves safety and decision-making. Current practice often forces clinicians to make assumptions while waiting for lab results, sometimes leading to under- or over-treatment. With a quick point-of-care reading, the new test could help avoid delays in identifying children who require urgent intervention.

The potential impact extends beyond individual diagnoses. Fever is one of the most common reasons children visit emergency departments, and many are prescribed antibiotics unnecessarily. A reliable rapid test could reduce avoidable antibiotic use, improve early detection of serious infections, and support efforts to combat antimicrobial resistance.

“This trial will now tell us whether the test has a role in the NHS and if clinicians will use it to help make faster, more accurate decisions so children receive the right treatment faster,” said Dr Ruud Nijman, pediatric consultant at St Mary’s Hospital and honorary clinical senior lecturer at Imperial College London. “If successful, this test has the potential to completely change the way we treat infections and help us diagnose with more certainty, stopping illnesses escalating to something more serious.

Related Links:
St Mary’s Hospital, Imperial College Healthcare NHS Trust


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automated Urinalysis Solution
UN-9000
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.